A double masked, placebo controlled clinical trial, of topical 2% ketoconazole cream with lid hygiene, for the treatment of seborrhoeic and mixed seborrhoeic/staphylo coccal blepharitis was conducted.
Blepharitis is a common condition, which is difficult to treat. 1 Patients complain of burn ing and itching of the eyes, photophobia, foreign body sensation, tearing and an ocular discharge that builds up on the lid margin to produce unsightly crusting.
The management of blepharitis is often inadequate, and patients frequently endure prolonged periods of ocular discomfort. In the long term more severe problems may develop, such as conjunctival scarring and drying, trichiasis and corneal ulcers and vascularisation.
Although our understanding of blepharitis has been improved with the introduction of a new classification of the disease, 2 its patho genesis particularly the role of bacteria and other organisms, is still unclear.
Staphylococcal blepharitis is often associ ated with the presence of coagulase positive Staphylococcus aureus on the eyelids. 3 ,4 How ever, a large number of patients have coag ulase negative Staphylococci, usually considered as non-pathogenic. 5 Seborrhoeic blepharitis, a particularly chronic form of the disease, is associated with generalised seborrhoeic dermatitis. Recent evidence points to the role of the yeast Pity rosporum (Malasszia) species, in seborrhoea and dandruff, for marked improvement in the condition has been obtained with the use of the antifungal agent, ketoconazole. 6 This drug, a Pityrosporicidal agent with no anti bacterial activity, 7 is now used topically in the treatment of seborrhoeic dermatitis. 8, 9 Pityrosporum orbiculare and ovale have been identified on the lid margin from lid scrapings, in patients with blepharitis, in sev era\ \\tud\.e\\, but the 1lre\\ence ot the m:gan\.�m has been considered to be coincidental rather than causal in the disease.1 (J. . . 12 The standard treatment of blepharitis con sists of meticulous lid hygiene, with cleansing and debridement of squames and crusts on the eyelids, with cotton buds and shampoo, fol lowed by antibiotics or antiseptic solu tions.1 3 ,1 4 Often this treatment is inadequate to control the problem and patients are rarely asymptomatic.
To record any therapeutic benefits of a Pity rosporicidal agent in the disease and conse quently explore the possibility of a role in blepharitis for Pityrosporum, a double masked, placebo controlled trial of ketocona zole 2% cream as an adjunct to standard lid hygiene was conducted. The method and results of this trial are presented, together with a discussion of findings.
The trial was conducted in the Ophthal mology Department of the Royal Hallam shire Hospital, Sheffield, with full ethical committee approval.
Method
Patients were recruited for the study from the ophthalmic out-patient and casualty depart ments of the Royal Hallamshire Hospital. Forty symptomatic patients with seborrhoeic or mixed seborrhoeic/staphylococcal blephar itis not currently receiving treatment were assessed for inclusion in the trial.
Patients were excluded if they were receiv ing topical or systemic antibiotics or anti inflammatory drugs, or if significant active corneal disease was present. Contact lens wearers, women of child bearing potential not using contraception and patients known to be allergic to imidazole antifungals were also excluded.
Informed, written consent was obtained from all patients after a full explanation of the nature of the trial, before entry.
At first visit (week 1) details of the patients past ocular and medical history were taken, with particular attention to skin or rheumatic diseases. A detailed ocular examination was made, noting abnormalities of the lid position, eyelashes, meibomian glands, con junctiva and cornea. Lid scaling, ulceration, meibomian gland inflammation and sebor rhoea, conjunctival scarring and injection together with comea\ \'lunctate fiuorescein staining were clinically graded as absent, mild, moderate and severe.
Swabs for bacterial culture were taken from the lid margins using standard techniques, with moistened swabs, placed in culture medium.
Skin scrapings from the eyelids were taken with a sterile surgical blade and examined after mounting in Parkers stain.1 5 Scrapings were also cultured on Dixon agar1 6 and incu bated at 35°C for seven days.1 6
In addition more than half of the patients had a quantitative examination of lid mycol ogy by the application of a strip of transparent adhesive tape to the upper lid which after removal contained an imprint of the super ficial skin squames and fungi. After staining with Parker's stain the number of Pityrospo rum yeasts on the eyelids could be counted and expressed as a number per square centimetre.
Each patient's symptoms were assessed using a visual analogue scale. They were asked to indicate the severity of five common symptoms encountered with blepharitis (itch ing, burning, discharge, foreign body sensa tion and lid scaling) by placing a cross on a line scale 10 cm long, from no symptoms to worst ever. Scoring of symptom severity was measured directly in millimetres with a ruler.
After examination patients were instructed in lid hygiene, using cotton buds moistened with Johnson and Johnson baby shampoo. Following lid hygiene they were asked to apply the cream provided on to the lid mar gins and the skin of the upper and lower lids. The cream either contained ketoconazole 2% in a lanolin base or placebo of identical for mulation but without the antifungal agent.
Patients were randomly allocated placebo or ketoconazole in a double masked manner.
Visual analogue scales were completed at weekly intervals for the nine weeks of the trial. Lid hygiene was continued for the whole study period but the cream was maintained only up to week five.
The patients were reassessed at two weekly intervals (weeks 1, 3, 5, 7 and 8) and the sever ity of the disease was recorded. Microbiology of the lids was repeated at each visit.
Results
Forty patients entered the trial; 20 used keto conazole cream and 20 placebo cream. All patients used lid hygiene. Only three patients were withdrawn during the trial. One patient, on ketoconazole, developed a probable, but unconfirmed, hypersensitivity skin reaction one week after commencing the drug. She stopped the treatment, received topical hydrocortisone from her own general prac titioner and suffered no long-term problems. A second patient receiving ketoconazole developed an unrelated viral keratoconjunc tivitis and was withdrawn for treatment of this condition. The third patient was using pla cebo and developed marginal keratitis. This was treated by his general practitioner with topical steroid and he was therefore with drawn from the trial.
In the ketoconazole group there were eleven females, and nine males. Mean age was 52 years with a range of 20 to 80 years. Mean duration of symptoms was two years.
The placebo group was made up of ten females and ten males, with a mean age of 49 years and an age range of 21-78 years. Mean duration of symptoms was 3. 5 years.
Where appropriate, statistical analysis with a hypothesis test for means, is given, unless otherwise stated.
Visual Analogue Scales
Visual analogue scales were completed weekly during the nine weeks of the trial. Scores of 0-100 were calculated by direct measurement along the scale and mean scores for each symptom (itching, burning, dis charge, foreign body sensation and scaling) for weeks 1 to 9 are shown in Tables I and II. The number of scales available for analysis varied each week because patients were with drawn from the trial, occasionally could not attend or simply forgot to complete the scale at home. However the data available for each week was similar for both ketoconazole and placebo groups.
All patients improved with treatment, with a few differences between the ketoconazole and placebo groups. There was a wide varia- tion in scoring symptom severity between each visit was calculated by taking the mean each patient, and this is reflected in the large value from both eyes of each patient and then standard deviations, deriving the mean value from all of these Foreign body sensation remained high until values. The results are presented in Table III . week seven suggesting that the lanolin base
The mean number of Pityrosporum yeasts for both placebo and ketoconazole may have at week one was greater in the placebo group, seen slightly irritant.
than in the ketoconazole group. (difference 1040 cm-2 p = 0.24).
Mycology
Both groups showed a significant reduction Pityrosporum yeasts were identified in serap-in the number of organisms by week five ings from 39 of the 40 patients in the study.
(reduction of 1519 cm-2 in the ketoconazole The mean Pityrosporum count from exam-group, and 2486 cm-2 in the placebo group ination of sellotape impressions (expressed as p = 0.01). a number of yeasts per cm2) for each group at After the cream was stopped there was a 
Clinical Features
Lid scaling, conjunctival injection and sebor rhoea were judged as absent, mild, moderate or severe, and scored from 0-3. The mean total score for both ketoconazole and placebo groups are shown in Table IV .
Both groups showed a significant improve ment in mean score from weeks one to three, which was sustained (p<O.I, one-sided Mann-Whitney). There was no difference between the two groups.
At week five, the overall clinical impression of the severity of blepharitis was assessed by 
Bacteriology
The results form the bacterial swabs are pre sented in Tables V and VI. The most commonly cultured organisms were coagulase-negative Staphylococci. There was no difference between the ketoco nazole and the placebo groups, in bacterial colonisation of the lids. Both groups showed a slight reduction in coagulase negative staphy lococcal cultures, during the trial but few had no bacterial growth. The total number of bac terial species cultured exceeds the total cul tures undertaken as some patients had multiple bacterial growths.
Discussion
Blepharitis is a chronic disease with inflam mation of the eyelids leading to secondary conjunctivitis and ocular discomfort. It occurs commonly, frequently beginning in child hood, and continuing throughout life. In many cases, the problems associated with blepharitis are minor, and at most irrita ting. However in a considerable number of patients it is a cosmetic problem, a source of constant ocular and peri-ocular discomfort, and a cause of styes, chalazia and trichiasis. In severe cases, it is associated with the develop ment of corneal ulceration, vascularisation, thinning and even perforation.
Initially Of these, the mixed seborrhoeic/staphylo coccal variety is the most common, and makes up most of the patients included in this study.
Staphylococci, particularly S. aureus and coagulase negative S. epidermidis, have been implicated in the aetiology of blepharitis for many years, but their actual role in the patho genesis of the disease is as yet unclear. 3--5 , 1 6 Theories include the production of staphylo coccal toxin and lipases, direct bacterial pathogenicity, and tissue hypersensitivity to bacterial antigen. 18, 19 Patients with a Staphylococcal blepharitis have exacerbations and remissions of the disease, with periods of acute, short-lived inflammation. These attacks are usually accompanied by conjunctivitis and keratitis. The lids show hard brittle scales of desqua mated skin, often forming around, and being lifted from the surface by the lashes, and known as collarettes. Beneath these colla rettes are shallow ulcers. Secondary changes in the lids are telangiectasis, trichiasis, pol iosis and madarosis.
Lid scales in seborrhoeic dermatitis are usually greasy, or oily, and local lid inflam mation less severe. Staphylococcal super infection is frequent, producing the common mixed picture. 2o
The meibomian glands are specialised seba ceous glands in the posterior lamella of the eyelid. They may be primarily or secondarily involved in blepharitis. Meibomian sebor rhoea is characterised by the production of copious amounts of lipid that appears on the lid margin as small oil globules, or as col-lections of waxy material. Sometimes the secretion is in such large amounts that it accu mulates as a frothy discharge at the lateral canthus.21
Meibomian gland inflammation may occur, with acute, or chronic meibomitis contribut ing to the disease morbidity. Examination of these glands in vivo and histologically, have shown gross abnormalities of the gland structure.22 p ovale and P orbiculare have often been implicated in seborrhoeic dermatitis. Contro versy has existed as to whether the organism is primary in the aetiology of seborrhoea or merely a co-incidental saprophyte. The two species are separated by the shape of the cell, oval in P ovale and spherical in P orbiculare, although taxonomists currently classify them as forming one species in the genus Malasse zia. 23 They both require lipid for growth and therefore culture is not straightforward. Attempts were made to isolate the yeasts from eyelid specimens in this study but diffi culty in obtaining sufficient scrapings and the problem with transportation to a laboratory sufficiently equipped for its culture resulted in a low recovery rate. From a total of 324 cul tures, P orbiculare was grown from six patients and P ovale from 23. By contrast the organism was seen in virtualy all.
Pityrosporum spp. in skin disease is reviewed by Shuster,2 4 and its role as the primary agent in pityriasis versicolor, sebor rhoeic dermatitis and dandruff is now established.
Similarly these species have been impli cated in blepharitis, and more especially in seborrhoeic blepharitis. Thygeson describes P ovale in all of his patients with seborrhoeic blepharitis, having found it in lid scrapings.lO Gots et ai, confirmed this in their series but were disappointed in not being able to trans fer the disease to animals or human volun teers.11 However Parunovic in detailed animal inoculation experiments was unable to prove a causal relationship between Pityrosporum and the disease. He concluded that the yeast existed as a mere saprophyte on the lids of most patients, and was not pathogenic. 12 This study has similarly confirmed the pres ence of Pitysrosporum often in large numbers on the lids of patients with blepharitis. It is clear from the results presented that the improvement in some symptoms and the sev erity of the disease parallels the reduction in the number of the organisms seen. However this does not prove that the yeast is producing the disease, as an improvement in the con dition may make the environment hostile enough to decrease numbers.
The effectiveness of oral ketoconazole in the clearance of Pityrosporum folliculitis was reported in 1981 by Neumann This study has evaluated the use of a four week course of topical ketoconazole cream in the management of blepharitis, by assessing any improvement in symptoms and signs of inflammation.
A reduction in yeast count was seen in both ketoconazole and placebo treated patients so that lid hygiene and possibly the mechanical effect of using a cream on the eyelid is sufficient to reduce Pityrosporum numbers on the lid margin. Johnson and Johnson Baby Shampoo contains propylene glycol which is effective in the treatment of pityriasis versicolor, and may in itself be pi tyro sporicidal. 7 This of course provides no proof that the organism is a primary pathogen as it may well only reside in inflamed and oedematous skin, but in studies with seborrheoic dermatitis a reduction in the organism did also correlate with improvement in the condition. Further studies with anti pityrosporal agents alone need to be conducted to establish if seborrhoeic blepharitis has a fungal aetiology.
There was a difference in the overall clinical appearance of the condition with 69% of patients in the ketoconazole group normal ised or markedly improved, as compared to only 42% of the placebo group.
The clinical symptoms of the two groups, as recorded with the visual analogue scales, were more or less similar. However some important problems are worthy of mention in the interpretation of the visual analogue scales.
The initial scoring of the symptoms was often low, so that the mean score before treat ment was around 30. This made any signifi cant improvement due to treatment very difficult to detect, purely on the scale alone. The low initial scores are partly due to a poor understanding of the nature of the scale by the patient with a consequent improvement in understanding as the weeks went by. Often scores were given as low when the patient expressed their symptoms as very severe. The protocol required the patients record their own score after an explanation without help from the investigator, so this error had to remain.
Furthermore, several patients stated that their symptoms at the time of filling in the scale were relatively mild although the pre vious day they had been more severe. Ble pharitis is a variable condition and so a single assessment of symptom severity prior to treat ment could be artificially low.
No attempt has been made to explain the pathogenesis of blepharitis and in particular the specific role of Pityrosporum spp. The role of this yeast in seborrhoeic dermatitis is clear, although the actual pathogenesis remains unknown.
Pityrosporum is lipophilic and contains enzymes for the breakdown of fatty acids and sterols.7 Lipoxygenase activity has also been demonstrated. 27 Whether this is relevant in the development of symptoms is as yet unknown. It is possible that the yeast may not be primarily pathogenic but that a hypersensi tivity response occurs in some people. Remo val of the yeast will still, nonetheless lead to resolution of the condition by removing the antigenic stimulus. This mechanism is already accepted as the probable explanation of sta phylococcal lid disease, especially when non pathogenic staphylococci are involved. A rab bit model of blepharitis requires the prior sensitisation of the animal with intravenous antigen, before the introduction of the bac teria on the lid margin will produce the disease. 28 It is possible that this mechanism may occur in Pityrosporallid disease.
